{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:18:47Z","timestamp":1793755127127,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3209,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1NR010162-01A1"],"award-info":[{"award-number":["RO1NR010162-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1CA1222292.01"],"award-info":[{"award-number":["RO1CA1222292.01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1CA124481-01"],"award-info":[{"award-number":["RO1CA124481-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["PEP-08-299-01-PC1"],"award-info":[{"award-number":["PEP-08-299-01-PC1"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinician Investigator Program, Royal College of Physicians and Surgeons of Canada. The authors declare no conflicts of interest"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jpainsymman.2010.06.021","type":"journal-article","created":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T04:17:32Z","timestamp":1296274652000},"page":"788-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Association Between Serum Cortisol and Testosterone Levels, Opioid Therapy, and Symptom Distress in Patients with Advanced Cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"Rony","family":"Dev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra I.","family":"Nooruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Yennurajalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Del Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.06.021_bib1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-2007-1014801","article-title":"Endocrine actions of opioids","volume":"16","author":"Pfeiffer","year":"1984","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/cncr.20028","article-title":"Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids","volume":"100","author":"Rajagopal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2265.2007.02779.x","article-title":"Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment","volume":"66","author":"Mussig","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib4","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.294.19.2481","article-title":"Adrenal insufficiency","volume":"294","author":"Salvatori","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2796.2005.01483.x","article-title":"Chronic fentanyl application induces adrenocortical insufficiency","volume":"257","author":"Oltmanns","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib6","first-page":"2495","article-title":"Hypogonadism in male patients with metastatic cancer prior to chemotherapy","volume":"42","author":"Chlebowski","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib7","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/jc.2006-2744","article-title":"Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study","volume":"92","author":"Greenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib8","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/cncr.22339","article-title":"The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study","volume":"107","author":"Crasser","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib9","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","article-title":"Validation of the Edmonton Symptom Assessment Scale","volume":"88","author":"Chang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.3003907","article-title":"Stress-induced inhibition of reproductive functions: role of endogenous corticotrophin-releasing factor","volume":"231","author":"Rivier","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0006-8993(86)90887-5","article-title":"Corticotropin-releasing factor (CRH) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro","volume":"377","author":"Nikolarakis","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/endo-122-3-1034","article-title":"Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotrophin releasing factor","volume":"122","author":"Almeida","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1210\/endo-119-6-2445","article-title":"Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat","volume":"119","author":"Petraglia","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000124463","article-title":"Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man","volume":"42","author":"Grossman","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0196-9781(83)90012-8","article-title":"Predominant involvement of mu- rather than delta- or kappa-opiate receptors in LH secretion","volume":"4","author":"Pfeiffer","year":"1983","journal-title":"Peptides"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4530(88)90046-7","article-title":"Human studies on the \u03bc opiate receptor agonist fentanyl: neuroendocrine and behavioral responses","volume":"13","author":"Hoehe","year":"1988","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib17","first-page":"178","article-title":"Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men","volume":"40","author":"Pende","year":"1986","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0700971","article-title":"The effects of spiradoline (U-62066E), a \u03ba-opioid receptor agonist, on neuroendocrine function in man","volume":"120","author":"Ur","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/1097-0142(19870701)60:1<103::AID-CNCR2820600119>3.0.CO;2-Y","article-title":"Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis","volume":"60","author":"Redman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib20","first-page":"269","article-title":"Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis","volume":"19","author":"Palm","year":"1997","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00009","article-title":"Diagnosis of adrenal insufficiency","volume":"139","author":"Dorin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpainsymman.2003.11.004","article-title":"The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain","volume":"28","author":"Ozyuvaci","year":"2004","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1526-4637.2002.02019.x","article-title":"Normalization of serum cortisol concentration with opioid treatment of severe chronic pain","volume":"3","author":"Tennant","year":"2002","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archsurg.143.12.1147","article-title":"Opioid contribution to decreased cortisol levels in critical care patients","volume":"143","author":"Daniell","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib25","first-page":"233","article-title":"Cancer cachexia and depressive states: a neuro-endocrine-immunological disease?","volume":"51","author":"Iwagaki","year":"1997","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000658-198811000-00017","article-title":"Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients","volume":"208","author":"Drott","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1191\/0269216303pm780oa","article-title":"Symptoms in advanced cancer: relationship to endogenous cortisol levels","volume":"17","author":"Lundstrom","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib28","first-page":"284","article-title":"Melatonin and cortisol serum levels in lung cancer patients at different stages of disease","volume":"11","author":"Mazzoccoli","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00964585","article-title":"Tumor host relations. II. Influence of tumor extent and tumor site on plasma cortisol of patients with malignant diseases","volume":"93","author":"Schaur","year":"1979","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2010.06.021_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00006842-200005000-00002","article-title":"Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer","volume":"62","author":"Cruess","year":"2000","journal-title":"Psychosom Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410010274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410010274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:52Z","timestamp":1760130292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392410010274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0885392410010274"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.06.021","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Serum Cortisol and Testosterone Levels, Opioid Therapy, and Symptom Distress in Patients with Advanced Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}